ARTICLE | Clinical News
Corlux mifepristone: Additional Phase III data
January 17, 2011 8:00 AM UTC
Corcept Therapeutics Inc. (NASDAQ:CORT), Menlo Park, Calif. Product: Corlux mifepristone Business: Other Molecular target: Progesterone receptor; Cortisol receptor GR-2 Description: Progesterone an...